Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
5
×
Tags
eli lilly
5
×
life sciences
national blog main
biotech
clinical trials
fda
amgen
boston blog main
boston top stories
new york blog main
san francisco blog main
calcitonin gene-related peptide
chronic migraine
episodic migraine
europe blog main
indiana blog main
indiana top stories
migraine
national
national top stories
new york top stories
san francisco top stories
teva pharmaceutical
abbvie
alder biopharmaceuticals
allergan
biohaven
biontech
black diamond therapeutics
bladder cancer
blueprint medicines
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
cgpr
curevac
david rind
What
medicines
5
×
new
5
×
class
drug
fda
migraine
approval
approved
cancer
companies
developed
nod
pain
starts
won
adults
allergan
amgen
announced
bets
bio
biotech
black
candidates
clinic
comes
cut
date
deal
decision
diamond
effective
eli
eluded
enticed
evidence
gets
hasn’t
head
headache
Language
unset
Current search:
medicines
×
photo
×
new
×
" eli lilly "
×
@xconomy.com
4 years ago
Black Diamond Lines Up IPO as Lead Cancer Drug Nears Clinic
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
With $45M Translate Bio Deal, Sanofi Bets Again on mRNA Vaccines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines